Never mind the fact that 17 billion is on par with the annual R&D spend at one Pharma company.
I think a more interesting comparison would be all national funding for drug R&D versus all corporate R&D funding. This could be done on an annual basis or historic.
NIH budget was 43 billion in 2021 for all healthcare sectors
Top 10 US Drug company[1] R&D budgets [2] were:
1: Johnson & Johnson $15 Billion
2: Pfizer $14 Billion
3: Merck $13 Billion
4: AbbVie $7 Billion
5: Bristol $11 Billion
6: Abbott $3 Billion
7: Amgen $5 Billion
8: Gilead $5 Billion
9: Eli Lilly $7 Billion
10: Biogen 2.5 Billion
Total 91+ Billion
Keep in mind that those are only US headquartered drug companies, and some of the biggest players like Roche and Novartis are in Europe[3]
https://www.pharmapproach.com/top-10-pharmaceutical-companie...
https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnso...
https://www.fiercebiotech.com/special-reports/top-10-pharma-...